An overview of the history of genome-wide association studies (GWAS) for osteoporosis, and the existing challenges and recent developments in GWAS in the bone field.
Investigators sought to identify risk factors associated with the development of immune-related endocrine events in patients with cancer undergoing treatment with immune checkpoint inhibitors.
Investigators report results from MAESTRO-NAFLD-1, a phase 3, randomized, double-blind, placebo-controlled trial evaluating the effect of treatment with resmetirom in patients with hypothyroidism and nonalcoholic steatohepatitis.
Acella Pharmaceuticals announced the voluntary recall of several lots of NP Thyroid (thyroid tablets) 15mg, 30mg, 60mg, 90mg, and 120mg due to subpotency.
Patients with hypoparathyroidism are at increased risk of soft tissue calcification, including calcification of the basal ganglia in the brain. In this study, Mayo Clinic researchers explore the prevalence of basal ganglia calcification in patients with hypoparathyroidism.
Thyrotropin regulates the production of thyroid hormones and their levels during gestation can have a significant effect on pregnancy outcomes. In this featured study from JAMA Network Open, researchers show how low and high maternal thyrotropin levels can increase the risk for adverse pregnancy outcomes.
